Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,594 | -13,160 | -6,789 | -65,904 | -53,672 |
| Depreciation Amortization | 8,012 | 5,235 | 2,485 | 9,372 | 6,978 |
| Accounts receivable | -15,814 | -21,227 | -11,013 | 13,072 | 7,675 |
| Accounts payable and accrued liabilities | -1,155 | -1,145 | -273 | 800 | 12,768 |
| Other Working Capital | -13,727 | -17,588 | -12,527 | -18,286 | -18,282 |
| Other Operating Activity | 24,481 | 27,103 | 13,394 | 1,438 | -7,595 |
| Operating Cash Flow | $-8,797 | $-20,782 | $-14,723 | $-59,508 | $-52,129 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,574 | -2,817 | -1,945 | -13,911 | -10,163 |
| Investing Cash Flow | $-3,574 | $-2,817 | $-1,945 | $-13,911 | $-10,163 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 151,750 | 151,750 |
| Debt Repayment | -16 | -16 | -10 | -102,036 | -102,027 |
| Common Stock Issued | 1,096 | 472 | N/A | 64,820 | N/A |
| Other Financing Activity | -1,074 | -866 | -640 | -5,682 | -3,614 |
| Financing Cash Flow | $6 | $-410 | $-650 | $108,852 | $46,109 |
| Beginning Cash Position | 86,522 | 86,522 | 86,522 | 51,089 | 51,089 |
| End Cash Position | 74,157 | 62,513 | 69,204 | 86,522 | 34,906 |
| Net Cash Flow | $-12,365 | $-24,009 | $-17,318 | $35,433 | $-16,183 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,797 | -20,782 | -14,723 | -59,508 | -52,129 |
| Capital Expenditure | -3,574 | -2,817 | -1,945 | -13,911 | -10,163 |
| Free Cash Flow | -12,371 | -23,599 | -16,668 | -73,419 | -62,292 |